Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine
R. Menezes Martinsa,1, A.R.S. Périsséb, L.A.B. Camachob, M.L. Lealc, M.L.S. Maiaa, A. Hommad, E. Jessourounc,
Corresponding author
ellen@bio.fiocruz.br

Corresponding author.
a Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil
b National School of Public Health, Fiocruz, Rio de Janeiro, RJ, Brazil
c Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil
d Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil
Read
3281
Times
was read the article
1453
Total PDF
1828
Total HTML
Share statistics
Article information
ISSN: 14138670
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 6 17 4 21
2025 5 95 42 137
2025 4 102 35 137
2025 3 68 35 103
2025 2 44 26 70
2025 1 40 31 71
2024 12 34 24 58
2024 11 37 33 70
2024 10 27 29 56
2024 9 42 22 64
2024 8 40 43 83
2024 7 85 38 123
2024 6 39 37 76
2024 5 27 21 48
2024 4 35 29 64
2024 3 53 21 74
2024 2 43 27 70
2024 1 33 29 62
2023 12 16 34 50
2023 11 23 39 62
2023 10 26 37 63
2023 9 33 37 70
2023 8 15 18 33
2023 7 26 21 47
2023 6 21 12 33
2023 5 39 21 60
2023 4 28 19 47
2023 3 51 26 77
2023 2 34 36 70
2023 1 20 31 51
2022 12 42 50 92
2022 11 48 34 82
2022 10 45 27 72
2022 9 30 57 87
2022 8 24 38 62
2022 7 25 38 63
2022 6 76 39 115
2022 5 38 32 70
2022 4 28 44 72
2022 3 60 54 114
2022 2 66 52 118
2022 1 67 45 112
2021 12 70 69 139
2021 11 16 17 33
Show all

Follow this link to access the full text of the article

The Brazilian Journal of Infectious Diseases